FENC Fennec Pharmaceuticals | $6.24 +4.2% | 12/20/2024 | Reiterated by | Wedbush | - | Outperform | $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/20/2024 |
DRI Darden Restaurants | $183.94 -1.9% | 12/20/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $200.00 -> $220.00 | N/A | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/20/2024 |
XMTR Xometry | $41.85 +0.4% | 12/20/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $48.00 | N/A | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 12/20/2024 |
LAC Lithium Americas | C$4.50 +5.4% | 12/19/2024 | Upgraded by | Wedbush | Analyst D. Ives | Hold | | N/A | View details for Wedbush rating of Lithium Americas (TSE:LAC) on 12/19/2024 |
SNOW Snowflake | $161.20 -3.1% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 12/18/2024 |
ESTC Elastic | $102.77 -0.8% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/18/2024 |
|
VTR Ventas | $59.02 +0.4% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/19/2024 |
TRIP Tripadvisor | $13.93 +1.0% | 12/19/2024 | Reiterated by | Wedbush | - | Neutral | $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 12/19/2024 |
LEN Lennar | $138.33 +0.2% | 12/19/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/19/2024 |
HMST HomeStreet | $10.63 -2.5% | 12/19/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $12.00 -> $15.00 | N/A | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 12/19/2024 |
TTD Trade Desk | $122.70 -1.8% | 12/19/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/19/2024 |
INOD Innodata | $44.18 +2.7% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $48.00 | N/A | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 12/19/2024 |
LAC Lithium Americas | $3.14 +5.7% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Neutral | $5.00 | N/A | View details for Wedbush rating of Lithium Americas (NYSE:LAC) on 12/19/2024 |
OKLO Oklo | $21.92 +1.9% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $26.00 | N/A | View details for Wedbush rating of Oklo (NYSE:OKLO) on 12/19/2024 |
SWI SolarWinds | $14.36 -0.6% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $20.00 | N/A | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 12/19/2024 |
OS Onestream | $29.37 -1.0% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $40.00 | N/A | View details for Wedbush rating of Onestream (NASDAQ:OS) on 12/19/2024 |
TXRH Texas Roadhouse | $180.35 -0.6% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 -> $200.00 | N/A | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/19/2024 |
MNRO Monro | $25.19 +0.1% | 12/18/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $31.00 | N/A | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 12/18/2024 |
BLDR Builders FirstSource | $149.78 -0.5% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $230.00 -> $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 12/18/2024 |
CRM Salesforce | $343.02 -0.2% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $425.00 -> $425.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 12/18/2024 |
MU Micron Technology | $90.00 -0.1% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 -> $140.00 | N/A | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/17/2024 |
CSR Centerspace | $65.70 -0.5% | 12/17/2024 | Initiated by | Wedbush | Analyst R. Anderson | Neutral | $72.00 | N/A | View details for Wedbush rating of Centerspace (NYSE:CSR) on 12/17/2024 |
GEO The GEO Group | $28.19 +2.5% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 12/17/2024 |
IDYA IDEAYA Biosciences | $25.30 -1.2% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
NBIX Neurocrine Biosciences | $136.03 +0.5% | 12/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $148.00 -> $148.00 | N/A | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
SOUN SoundHound AI | $20.61 -5.3% | 12/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $10.00 -> $22.00 | N/A | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 12/16/2024 |
HOV Hovnanian Enterprises | $134.72 -0.1% | 12/16/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $155.00 | N/A | View details for Wedbush rating of Hovnanian Enterprises (NYSE:HOV) on 12/16/2024 |
SLDB Solid Biosciences | $4.12 -1.0% | 12/12/2024 | Upgraded by | Wedbush | Analyst L. Chico | Strong-Buy | | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
RH RH | $408.74 +2.6% | 12/13/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $430.00 -> $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 12/13/2024 |
SLDB Solid Biosciences | $4.12 -1.0% | 12/13/2024 | Initiated by | Wedbush | - | Outperform | $16.00 | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/13/2024 |
PZZA Papa Johns International | $39.22 +0.8% | 12/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.25 -2.3% | 12/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/12/2024 |
TTD Trade Desk | $122.70 -1.8% | 12/12/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/12/2024 |
LEN Lennar | $138.33 +0.2% | 12/12/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/12/2024 |
LOW Lowe's Companies | $247.68 0.0% | 12/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | N/A | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
ANAB AnaptysBio | $14.08 -3.2% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 -> $40.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
DBD Diebold Nixdorf | $43.72 -0.3% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 -> $60.00 | N/A | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 12/11/2024 |
ASO Academy Sports and Outdoors | $56.94 +2.3% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 | N/A | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/11/2024 |
TOL Toll Brothers | $126.50 +0.8% | 12/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/11/2024 |
VIRC Virco Mfg. | $10.53 +0.4% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 -> $17.00 | N/A | View details for Wedbush rating of Virco Mfg. (NASDAQ:VIRC) on 12/10/2024 |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
CMRX Chimerix | $3.01 +0.7% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 12/10/2024 |
TCRX TScan Therapeutics | $2.98 +0.3% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/10/2024 |
STRO Sutro Biopharma | $1.88 -0.3% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | N/A | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 12/10/2024 |
CXW CoreCivic | $21.31 +2.2% | 12/10/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $19.00 -> $30.00 | N/A | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 12/10/2024 |
TTWO Take-Two Interactive Software | $182.25 +0.2% | 12/9/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 12/9/2024 |
VOR Vor Biopharma | $0.85 -1.7% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 12/9/2024 |
IRON Disc Medicine | $63.19 -2.0% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
BEAM Beam Therapeutics | $28.62 -1.3% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | N/A | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
EBAY eBay | $63.76 -1.9% | 12/9/2024 | Initiated by | Wedbush | Analyst S. Devitt | Neutral | $70.00 | N/A | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 12/9/2024 |
WOOF Petco Health and Wellness | $3.90 -1.5% | 12/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.50 -> $6.00 | N/A | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 12/6/2024 |
GME GameStop | $30.79 +3.3% | 12/6/2024 | Reiterated by | Wedbush | - | Underperform | $10.00 | N/A | View details for Wedbush rating of GameStop (NYSE:GME) on 12/6/2024 |
ROKU Roku | $79.00 -2.0% | 12/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 -> $100.00 | N/A | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 12/6/2024 |
ARE Alexandria Real Estate Equities | $98.52 -0.7% | 12/6/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $120.00 -> $110.00 | N/A | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 12/6/2024 |
CHWY Chewy | $34.74 +3.0% | 12/5/2024 | Reiterated by | Wedbush | - | Outperform | $35.00 -> $39.00 | N/A | View details for Wedbush rating of Chewy (NYSE:CHWY) on 12/5/2024 |
VTR Ventas | $59.02 +0.4% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/3/2024 |
ARGX argenx | $624.50 +0.1% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $655.00 | N/A | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 12/3/2024 |
CVCO Cavco Industries | $441.80 -3.0% | 12/3/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $480.00 -> $480.00 | N/A | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 12/3/2024 |
TOL Toll Brothers | $126.50 +0.8% | 12/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/2/2024 |
NVCR NovoCure | $30.63 -0.6% | 12/2/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $24.00 -> $29.00 | N/A | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
RVMD Revolution Medicines | $43.92 -0.3% | 12/2/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 -> $70.00 | N/A | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 12/2/2024 |
APGE Apogee Therapeutics | $47.50 -0.4% | 12/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $87.00 -> $90.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 12/2/2024 |
UPST Upstart | $68.71 +0.5% | 12/2/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $60.00 -> $75.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 12/2/2024 |
WDC Western Digital | $61.06 +1.4% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 | N/A | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 11/29/2024 |
AAPL Apple | $254.00 -0.2% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/29/2024 |
PASG Passage Bio | $0.66 0.0% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $3.00 -> $4.00 | N/A | View details for Wedbush rating of Passage Bio (NASDAQ:PASG) on 11/29/2024 |
VYGR Voyager Therapeutics | $5.75
| 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $7.00 -> $11.00 | N/A | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 11/29/2024 |
DKS DICK'S Sporting Goods | $224.19 +2.5% | 11/27/2024 | Reiterated by | Wedbush | - | Neutral | $250.00 -> $215.00 | N/A | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/27/2024 |
IMAX IMAX | $24.30 -0.9% | 11/27/2024 | Reiterated by | Wedbush | - | Outperform | | N/A | View details for Wedbush rating of IMAX (NYSE:IMAX) on 11/27/2024 |
SRRK Scholar Rock | $44.55 -0.5% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $47.00 | N/A | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/25/2024 |
PLTR Palantir Technologies | $80.90 +0.4% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $57.00 -> $75.00 | N/A | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 11/25/2024 |
CRM Salesforce | $343.02 -0.2% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $325.00 -> $375.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/25/2024 |
SNOW Snowflake | $161.20 -3.1% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $190.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/25/2024 |
ESTC Elastic | $102.77 -0.8% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $135.00 | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 11/25/2024 |
NTAP NetApp | $118.07 -0.3% | 11/22/2024 | Reiterated by | Wedbush | - | Neutral | $120.00 | N/A | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/22/2024 |
CATX Perspective Therapeutics | $3.30 +15.8% | 11/21/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $20.00 -> $11.00 | N/A | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 11/21/2024 |
NVDA NVIDIA | $138.90 +3.1% | 11/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
WSM Williams-Sonoma | $185.86 +1.2% | 11/21/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $135.00 -> $175.00 | N/A | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 11/21/2024 |
SNOW Snowflake | $161.20 -3.1% | 11/21/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $130.00 -> $160.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/21/2024 |
MSFT Microsoft | $435.16 -0.3% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Ives | Outperform | $550.00 | N/A | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/19/2024 |
FTNT Fortinet | $96.47 -0.7% | 11/19/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $105.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
PTGX Protagonist Therapeutics | $40.49 -2.4% | 11/19/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | N/A | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/19/2024 |
ORKA Oruka Therapeutics | $20.91 +3.0% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $40.00 | N/A | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 11/19/2024 |
NFLX Netflix | $912.24 +0.4% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $800.00 -> $950.00 | N/A | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 11/18/2024 |
SWTX SpringWorks Therapeutics | $37.34 +4.9% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/18/2024 |
JACK Jack in the Box | $39.73 -2.5% | 11/18/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $60.00 -> $50.00 | N/A | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 11/18/2024 |
NTLA Intellia Therapeutics | $12.03 -1.2% | 11/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $14.00 -> $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
TSLA Tesla | $430.72 +2.3% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $400.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/18/2024 |
CMRX Chimerix | $3.01 +0.7% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 -> $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/18/2024 |
AAP Advance Auto Parts | $43.49 -0.1% | 11/15/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $55.00 -> $55.00 | N/A | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 11/15/2024 |
ASND Ascendis Pharma A/S | $139.42 +2.2% | 11/15/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $181.00 -> $181.00 | N/A | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
DIN Dine Brands Global | $29.22 -3.8% | 11/15/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/15/2024 |
BPMC Blueprint Medicines | $89.62 -0.6% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $135.00 | N/A | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 11/14/2024 |
ANAB AnaptysBio | $14.08 -3.2% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/14/2024 |
CAKE Cheesecake Factory | $47.41 -2.0% | 11/14/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $52.00 -> $59.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/14/2024 |
NVDA NVIDIA | $138.90 +3.1% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $138.00 -> $160.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/14/2024 |
RUM Rumble | $13.45 +87.1% | 11/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $8.00 | N/A | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 11/13/2024 |
RKT Rocket Companies | $11.43 -3.3% | 11/13/2024 | Reiterated by | Wedbush | - | Neutral | $18.00 -> $13.00 | N/A | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 11/13/2024 |
CAVA CAVA Group | $117.92 -0.9% | 11/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $155.00 -> $190.00 | N/A | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 11/13/2024 |
FATE Fate Therapeutics | $1.67 -0.9% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $5.00 | N/A | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 11/12/2024 |
SHOP Shopify | $109.71 +0.7% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $72.00 -> $115.00 | N/A | View details for Wedbush rating of Shopify (NYSE:SHOP) on 11/12/2024 |
SDHC Smith Douglas Homes | $27.31 -1.8% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $20.00 | N/A | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 11/12/2024 |
APGE Apogee Therapeutics | $47.50 -0.4% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $87.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 11/12/2024 |
ITOS iTeos Therapeutics | $7.25 -2.3% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 11/12/2024 |
IRON Disc Medicine | $63.19 -2.0% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 -> $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/12/2024 |
COGT Cogent Biosciences | $7.82 -0.3% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $11.00 | N/A | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 11/12/2024 |
ORIC ORIC Pharmaceuticals | $8.35 +1.7% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 11/12/2024 |
NUVL Nuvalent | $84.05 -0.2% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $115.00 | N/A | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 11/12/2024 |
DDI DoubleDown Interactive | $10.46 -3.0% | 11/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $16.25 -> $21.00 | N/A | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 11/12/2024 |
PINS Pinterest | $29.83 +1.2% | 11/11/2024 | Upgraded by | Wedbush | Analyst S. Devitt | Hold -> Strong-Buy | | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/11/2024 |
TSLA Tesla | $430.72 +2.3% | 11/11/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/11/2024 |
STKS ONE Group Hospitality | $2.84 +0.7% | 11/11/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $3.50 | N/A | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 11/11/2024 |
VOR Vor Biopharma | $0.85 -1.7% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 11/8/2024 |
SYRE Spyre Therapeutics | $23.35 -2.1% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $45.00 | N/A | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 11/8/2024 |
CAKE Cheesecake Factory | $47.41 -2.0% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/8/2024 |
EXPE Expedia Group | $189.01 +2.3% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $130.00 -> $180.00 | N/A | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
RIVN Rivian Automotive | $13.90 +0.5% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | N/A | View details for Wedbush rating of Rivian Automotive (NASDAQ:RIVN) on 11/8/2024 |
RNG RingCentral | $37.55 +0.3% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $36.00 -> $41.00 | N/A | View details for Wedbush rating of RingCentral (NYSE:RNG) on 11/8/2024 |
CCSI Consensus Cloud Solutions | $23.61 +0.1% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $32.00 | N/A | View details for Wedbush rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/8/2024 |
ABNB Airbnb | $134.39 +0.1% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $155.00 | N/A | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 11/8/2024 |
PINS Pinterest | $29.83 +1.2% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $37.00 -> $38.00 | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/8/2024 |
TOST Toast | $37.38 -0.5% | 11/8/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $35.00 -> $45.00 | N/A | View details for Wedbush rating of Toast (NYSE:TOST) on 11/8/2024 |
RDFN Redfin | $8.62 +1.2% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $8.00 -> $10.00 | N/A | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 11/8/2024 |
TTD Trade Desk | $122.70 -1.8% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $115.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 11/8/2024 |
FTNT Fortinet | $96.47 -0.7% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $78.00 -> $90.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/8/2024 |
VERA Vera Therapeutics | $42.76 +0.4% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $30.00 -> $38.00 | N/A | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 11/8/2024 |
GEO The GEO Group | $28.19 +2.5% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $25.00 -> $30.00 | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 11/8/2024 |
UPST Upstart | $68.71 +0.5% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $45.00 -> $60.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 11/8/2024 |
PEPG PepGen | $3.80 +4.7% | 11/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $19.00 -> $12.00 | N/A | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 11/8/2024 |
VIGL Vigil Neuroscience | $1.59 -6.8% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $23.00 -> $24.00 | N/A | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 11/8/2024 |
EWTX Edgewise Therapeutics | $30.03 -2.4% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $44.00 -> $45.00 | N/A | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 11/8/2024 |
TPX Tempur Sealy International | $55.54 +0.2% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $49.00 -> $55.00 | N/A | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 11/8/2024 |
ARHS Arhaus | $9.42 -2.3% | 11/8/2024 | Target Lowered by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $11.00 -> $10.00 | N/A | View details for Wedbush rating of Arhaus (NASDAQ:ARHS) on 11/8/2024 |
PZZA Papa Johns International | $39.22 +0.8% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 11/8/2024 |
GLUE Monte Rosa Therapeutics | $7.09 +2.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 11/7/2024 |
ACET Adicet Bio | $0.89 -2.6% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 11/7/2024 |
YOU Clear Secure | $26.83 +0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $24.00 -> $26.00 | N/A | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 11/7/2024 |
TRIP Tripadvisor | $13.93 +1.0% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $16.00 -> $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
CMRX Chimerix | $3.01 +0.7% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/7/2024 |
IKNA Ikena Oncology | $1.66 +7.1% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 11/7/2024 |
NTLA Intellia Therapeutics | $12.03 -1.2% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/7/2024 |
Mysterious drone activity triggers massive 1,366% surge (Ad) If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone.
But here’s what you really need to know:
An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%. 👉 Click here now to see how this signal works. |
FENC Fennec Pharmaceuticals | $6.24 +4.2% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 11/7/2024 |
RCUS Arcus Biosciences | $15.45 -0.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $36.00 | N/A | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 11/7/2024 |
SWTX SpringWorks Therapeutics | $37.34 +4.9% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/7/2024 |
GBIO Generation Bio | $1.12 -6.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 11/7/2024 |
TTWO Take-Two Interactive Software | $182.25 +0.2% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/7/2024 |
RITM Rithm Capital | $10.85 -0.8% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 | N/A | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 11/7/2024 |
GHLD Guild | $14.13 +0.4% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of Guild (NYSE:GHLD) on 11/7/2024 |
XNCR Xencor | $24.40 +1.1% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $38.00 | N/A | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 11/7/2024 |
MFA MFA Financial | $10.32 -0.7% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of MFA Financial (NYSE:MFA) on 11/7/2024 |
KROS Keros Therapeutics | $17.08 +0.3% | 11/7/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $84.00 | N/A | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/7/2024 |
NUVB Nuvation Bio | $2.70 +0.7% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 11/7/2024 |
MELI MercadoLibre | $1,722.00 +0.1% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $2,000.00 -> $2,200.00 | N/A | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
APP AppLovin | $340.15 -0.2% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $170.00 -> $270.00 | N/A | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
LYFT Lyft | $13.64 +0.5% | 11/7/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $12.00 -> $20.00 | N/A | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
BROS Dutch Bros | $52.86 -2.2% | 11/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $55.00 | N/A | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 11/7/2024 |
DIN Dine Brands Global | $29.22 -3.8% | 11/7/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/7/2024 |
ANAB AnaptysBio | $14.08 -3.2% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/6/2024 |
BLDR Builders FirstSource | $149.78 -0.5% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/6/2024 |
LGIH LGI Homes | $90.14 -1.2% | 11/6/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $125.00 | N/A | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 11/6/2024 |
GPRO GoPro | $1.10 +0.5% | 11/6/2024 | Reiterated by | Wedbush | - | Neutral | $1.50 | N/A | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 11/6/2024 |
MLTX MoonLake Immunotherapeutics | $52.25 +0.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/4/2024 |
KROS Keros Therapeutics | $17.08 +0.3% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/4/2024 |
BMRN BioMarin Pharmaceutical | $66.17 +0.8% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/4/2024 |
ASND Ascendis Pharma A/S | $139.42 +2.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
GFS GlobalFoundries | $44.24 +6.0% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 -> $60.00 | High | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 11/5/2024 |
INZY Inozyme Pharma | $2.95 -1.3% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 -> $12.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 11/5/2024 |
BEAM Beam Therapeutics | $28.62 -1.3% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/5/2024 |
TCRX TScan Therapeutics | $2.98 +0.3% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 11/5/2024 |
WING Wingstop | $289.72 -0.3% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $390.00 -> $390.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 11/5/2024 |
CRSR Corsair Gaming | $6.43 +2.6% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 11/5/2024 |
HEAR Turtle Beach | $15.96
| 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $19.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 11/5/2024 |
MLTX MoonLake Immunotherapeutics | $52.25 +0.2% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 -> $73.00 | Medium | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/5/2024 |
HMST HomeStreet | $10.63 -2.5% | 11/5/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $12.00 | High | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 11/5/2024 |
APP AppLovin | $340.15 -0.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst M. Pachter | Strong-Buy | | High | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/4/2024 |
IDYA IDEAYA Biosciences | $25.30 -1.2% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $52.00 | Medium | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/4/2024 |
SE SEA | $109.88 -0.7% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $84.00 -> $105.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 11/4/2024 |
SAFE Safehold | $19.02 -2.5% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $25.00 -> $23.00 | Medium | View details for Wedbush rating of Safehold (NYSE:SAFE) on 11/4/2024 |
WLDN Willdan Group | $38.23 -1.4% | 11/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $51.00 | Medium | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 11/4/2024 |
NCMI National CineMedia | $6.61 -1.6% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $6.00 -> $7.50 | High | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 11/4/2024 |
SRRK Scholar Rock | $44.55 -0.5% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $37.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/4/2024 |
CRBP Corbus Pharmaceuticals | $12.82 -1.4% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $51.00 | Medium | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 11/4/2024 |
IRON Disc Medicine | $63.19 -2.0% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $60.00 -> $75.00 | High | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/4/2024 |
KURA Kura Oncology | $8.94 -0.8% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 11/4/2024 |
RZLT Rezolute | $4.41 +0.5% | 11/4/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $112.00 | Low | View details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 11/4/2024 |
PTGX Protagonist Therapeutics | $40.49 -2.4% | 11/4/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | High | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/4/2024 |
W Wayfair | $45.19 -1.2% | 11/4/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $45.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 11/4/2024 |
UFPI UFP Industries | $113.28 -0.2% | 11/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $155.00 | Low | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 11/4/2024 |
SMCI Super Micro Computer | $32.12 +1.7% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $62.00 -> $32.00 | Medium | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 11/4/2024 |
DBD Diebold Nixdorf | $43.72 -0.3% | 11/4/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform | $50.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 11/4/2024 |
MHO M/I Homes | $134.03 +0.0% | 11/4/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $155.00 -> $185.00 | Medium | View details for Wedbush rating of M/I Homes (NYSE:MHO) on 11/4/2024 |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
CNK Cinemark | $30.53 -1.0% | 11/1/2024 | Downgraded by | Wedbush | Analyst A. Reese | Strong-Buy -> Hold | | Medium | View details for Wedbush rating of Cinemark (NYSE:CNK) on 11/1/2024 |
AMZN Amazon.com | $225.38 +0.2% | 11/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $225.00 -> $250.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 11/1/2024 |
BJRI BJ's Restaurants | $34.80 +0.1% | 11/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $43.00 -> $43.00 | High | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 11/1/2024 |
WEN Wendy's | $16.39 -1.6% | 11/1/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 -> $20.00 | Medium | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 11/1/2024 |
SBUX Starbucks | $87.23 -0.8% | 10/31/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $98.00 -> $95.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 10/31/2024 |
CMG Chipotle Mexican Grill | $61.61 -0.4% | 10/30/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $69.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 10/30/2024 |
CAKE Cheesecake Factory | $47.41 -2.0% | 10/30/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $48.00 -> $52.00 | High | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 10/30/2024 |
WSM Williams-Sonoma | $185.86 +1.2% | 10/30/2024 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $150.00 -> $135.00 | Medium | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 10/30/2024 |
CNK Cinemark | $30.53 -1.0% | 10/29/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $31.00 -> $32.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 10/29/2024 |
W Wayfair | $45.19 -1.2% | 10/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $60.00 -> $50.00 | Medium | View details for Wedbush rating of Wayfair (NYSE:W) on 10/28/2024 |
TXRH Texas Roadhouse | $180.35 -0.6% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $190.00 -> $200.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 10/25/2024 |
PEGA Pegasystems | $93.83 -1.5% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $100.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 10/25/2024 |
BKNG Booking | $5,060.38 +0.2% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $3,900.00 -> $4,750.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 10/25/2024 |
FND Floor & Decor | $102.18 +0.8% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $110.00 -> $110.00 | Medium | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 10/25/2024 |
WDC Western Digital | $61.06 +1.4% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $95.00 -> $95.00 | High | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 10/25/2024 |
TSCO Tractor Supply | $53.52 -0.7% | 10/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $54.00 -> $54.00 | Low | View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 10/25/2024 |
TYRA Tyra Biosciences | $14.05 +0.4% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 -> $28.00 | High | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 10/25/2024 |
IMNM Immunome | $11.00 +0.3% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $33.00 | High | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 10/25/2024 |
APGE Apogee Therapeutics | $47.50 -0.4% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $87.00 -> $87.00 | Low | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 10/25/2024 |
ROKU Roku | $79.00 -2.0% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 10/25/2024 |
BYON Beyond | $4.84 -4.9% | 10/25/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $25.00 -> $15.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 10/25/2024 |
EA Electronic Arts | $147.20 -0.4% | 10/25/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $170.00 -> $170.00 | Low | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 10/25/2024 |
RBLX Roblox | $59.43 -1.1% | 10/25/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $49.00 -> $49.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 10/25/2024 |
EGP EastGroup Properties | $160.90 -0.3% | 10/25/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $209.00 -> $209.00 | Medium | View details for Wedbush rating of EastGroup Properties (NYSE:EGP) on 10/25/2024 |
FCNCA First Citizens BancShares | $2,116.93 -0.6% | 10/25/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $2,150.00 -> $2,000.00 | Low | View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 10/25/2024 |
COLB Columbia Banking System | $27.08 -0.4% | 10/25/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $31.00 -> $35.00 | Medium | View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 10/25/2024 |
VLY Valley National Bancorp | $9.10 -0.7% | 10/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $10.00 -> $10.00 | High | View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 10/25/2024 |
PPBI Pacific Premier Bancorp | $24.92 -0.6% | 10/25/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $27.00 -> $25.00 | Medium | View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 10/25/2024 |
TOL Toll Brothers | $126.50 +0.8% | 10/25/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $148.00 -> $175.00 | Medium | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 10/25/2024 |
TMHC Taylor Morrison Home | $60.62 +1.5% | 10/25/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $65.00 -> $85.00 | Low | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 10/25/2024 |
COOP Mr. Cooper Group | $94.07 -1.1% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $115.00 -> $115.00 | Medium | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 10/24/2024 |
PMT PennyMac Mortgage Investment Trust | $12.86 -0.9% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $15.00 -> $15.00 | Low | View details for Wedbush rating of PennyMac Mortgage Investment Trust (NYSE:PMT) on 10/24/2024 |
TSLA Tesla | $430.72 +2.3% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | High | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 10/24/2024 |
SLM SLM | $27.35 -1.6% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $26.00 -> $26.00 | High | View details for Wedbush rating of SLM (NASDAQ:SLM) on 10/24/2024 |
PB Prosperity Bancshares | $75.62 +0.9% | 10/24/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Wedbush rating of Prosperity Bancshares (NYSE:PB) on 10/24/2024 |
LC LendingClub | $16.18 -1.7% | 10/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $14.00 -> $17.00 | High | View details for Wedbush rating of LendingClub (NYSE:LC) on 10/24/2024 |
CVBF CVB Financial | $21.83 -0.8% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 -> $20.00 | High | View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 10/24/2024 |
GOOGL Alphabet | $194.31 +1.5% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $205.00 -> $205.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 10/24/2024 |
ORLY O'Reilly Automotive | $1,207.86 -0.9% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $1,200.00 -> $1,200.00 | Medium | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 10/24/2024 |
TPH Tri Pointe Homes | $37.06 +0.1% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $42.00 -> $42.00 | High | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 10/24/2024 |
CCS Century Communities | $75.13 -0.8% | 10/24/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $90.00 -> $96.00 | High | View details for Wedbush rating of Century Communities (NYSE:CCS) on 10/24/2024 |
CATX Perspective Therapeutics | $3.30 +15.8% | 10/24/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $20.00 -> $20.00 | Low | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 10/24/2024 |
PFSI PennyMac Financial Services | $100.45 -1.2% | 10/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $130.00 -> $130.00 | High | View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 10/23/2024 |
HAFC Hanmi Financial | $23.46 -0.8% | 10/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 -> $21.00 | Medium | View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 10/23/2024 |
EWBC East West Bancorp | $96.04 +0.1% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $100.00 -> $110.00 | High | View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 10/23/2024 |
LOGI Logitech International | $82.65 +1.1% | 10/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $88.00 -> $88.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 10/23/2024 |
CATY Cathay General Bancorp | $47.53 +0.1% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $50.00 -> $52.00 | Medium | View details for Wedbush rating of Cathay General Bancorp (NASDAQ:CATY) on 10/23/2024 |
BANC Banc of California | $15.43 +0.1% | 10/23/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $18.00 -> $19.00 | Medium | View details for Wedbush rating of Banc of California (NYSE:BANC) on 10/23/2024 |
GM General Motors | $52.38 +1.1% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 10/23/2024 |
STX Seagate Technology | $88.21 +1.0% | 10/23/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform -> Outperform | $150.00 -> $150.00 | High | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 10/23/2024 |
TMHC Taylor Morrison Home | $60.62 +1.5% | 10/23/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $65.00 -> $65.00 | Low | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 10/23/2024 |
GPC Genuine Parts | $115.80 +0.1% | 10/23/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $145.00 -> $120.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 10/23/2024 |
ARE Alexandria Real Estate Equities | $98.52 -0.7% | 10/23/2024 | Target Lowered by | Wedbush | Analyst R. Anderson | Neutral -> Neutral | $130.00 -> $120.00 | Low | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 10/23/2024 |
ANRO Alto Neuroscience | $3.95 +1.5% | 10/23/2024 | Downgraded by | Wedbush | Analyst L. Chico | Outperform -> Neutral | $29.00 -> $4.00 | High | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 10/23/2024 |
MCD McDonald's | $290.69 -0.7% | 10/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $295.00 -> $295.00 | High | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 10/23/2024 |
DENN Denny's | $5.73 -2.4% | 10/23/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $7.00 -> $6.00 | High | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 10/23/2024 |
ETSY Etsy | $55.48 -2.3% | 10/21/2024 | Upgraded by | Wedbush | Analyst S. Devitt | Hold | | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 10/21/2024 |
NUVB Nuvation Bio | $2.70 +0.7% | 10/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $5.00 | High | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 10/22/2024 |
ZION Zions Bancorporation, National Association | $54.16 +0.9% | 10/22/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $52.00 -> $55.00 | Low | View details for Wedbush rating of Zions Bancorporation, National Association (NASDAQ:ZION) on 10/22/2024 |
BOKF BOK Financial | $108.75 -0.9% | 10/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 -> $115.00 | High | View details for Wedbush rating of BOK Financial (NASDAQ:BOKF) on 10/22/2024 |